
The session was held April 28, 2011, at the Scientific Education Research Institute (SERI), Thornton, CO. Participants in the session included: Dr. Ron Sokol, Director, Colorado Clinical and Translational Sciences Institute (CCTSI) - keynote speaker; Fred Mitchell, CEO, Beacon Biotechnology; Dr. Larry Gold, Chairman and Chief Science Officer, SomaLogic; David Brunel, CEO, Biodesix; and Dr. Pauline Gee, Chief Science Officer, BodySync. Vicki Jenings, Director of Business Relations, Fitzsimons Redevelopment Authority, moderated the session.
Video links:
Dr. Ron Sokol, Director, Colorado Clinical and Translational Sciences Institute (CCTSI) - first of four parts:
http://youtu.be/X8iiwUAzXH0?hd=1Fred Mitchell, CEO, Beacon Biotechnology - first of two parts:
http://youtu.be/VnEjbe1mHAY?hd=1David Brunel, CEO, Biodesix - first of two parts:
http://youtu.be/Ea2ot7Q8e4M?hd=1Panel Discussion - first of two parts:
http://youtu.be/DIEfNg9-a98?hd=1
No comments:
Post a Comment